Data / Form D filings / SYNNOVATION THERAPEUTICS, INC.
SYNNOVATION THERAPEUTICS, INC.: Form D filings
SYNNOVATION THERAPEUTICS, INC., a biotechnology company in Wilmington, DE, filed 4 Form D notices with the SEC between 2021 and 2023. The latest, on December 21, 2023, reports $15 million sold of a $102.5 million offering to 7 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 200 POWDER MILL ROAD, E500-1801, Wilmington, DE, 19803
- Phone
- (302) 521-9490
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1889137
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 21, 2023 | Amendment | $102,499,995 | $15,000,000 | $87,499,995 | 7 | Dec 8, 2023 | sec.gov |
| Dec 14, 2023 | New notice | $102,499,995 | $69,874,993 | $32,625,002 | 7 | Dec 8, 2023 | sec.gov |
| May 24, 2023 | New notice | $24,999,998 | $24,999,998 | 4 | May 17, 2023 | sec.gov | |
| Nov 26, 2021 | New notice | $19,999,625 | $11,999,775 | $7,999,850 | 1 | Nov 19, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Liangxing Wu | Executive Officer, Director | |
| Wenqing Yao | Executive Officer, Director | |
| Reid Huber | Director | |
| Ting Feng | Director |
Other biotechnology companies in Delaware that filed recently
- TCM Life Science Inc. $16,666 · Oct 26, 2026
- Amplica Bio, Inc. $30,000 · Sep 11, 2026
Every Form D from the week of Dec 18, 2023 · All recent filings in Delaware · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what SYNNOVATION THERAPEUTICS, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.